$1,318.00
This Market Spotlight report covers the Opioid-Induced Constipation (OIC) market, comprising key marketed and pipeline drugs, clinical trials, probability of success, licensing and asset acquisition deals, and epidemiology data, as well as presenting drug-specific revenue forecasts.
This Market Spotlight report covers the Opioid-Induced Constipation (OIC) market, comprising key marketed and pipeline drugs, clinical trials, probability of success, licensing and asset acquisition deals, and epidemiology data, as well as presenting drug-specific revenue forecasts.
Key Takeaways
CONTENTS
5 OVERVIEW
6 KEY TAKEAWAYS
7 DISEASE BACKGROUND
8 TREATMENT
8 Management of OIC with laxatives
8 Management of OIC with opioid antagonists
9 Management of OIC with Amitiza, a secretagogue chloride channel activator
10 EPIDEMIOLOGY
10 OIC, recent prevalence studies
10 OIC, challenges
11 MARKETED DRUGS
13 PIPELINE DRUGS
14 PROBABILITY OF SUCCESS
15 LICENSING AND ASSET ACQUISITION DEALS
15 Collegium, BioDelivery To Combine Pain Portfolios In Proposed Merger
16 REVENUE OPPORTUNITY
18 CLINICAL TRIAL LANDSCAPE
19 Sponsors by status
19 Sponsors by phase
21 BIBLIOGRAPHY
22 APPENDIX
LIST OF FIGURES
14 Figure 1: Probability of success in the gastroenterology (non inflammatory bowel disease)-other pipeline
18 Figure 2: Clinical trials in OIC
18 Figure 3: Top 10 drugs for clinical trials in OIC
19 Figure 4: Top 10 companies for clinical trials in OIC
19 Figure 5: OIC trials sponsors by status
20 Figure 6: OIC trials sponsors, by phase
LIST OF TABLES
12 Table 1: Marketed drugs for OIC
16 Table 2: Historical global sales, by drug ($m), 2017–21
17 Table 3: Forecasted global sales, by drug ($m), 2022–26
© Pharma Intelligence UK Ltd. This document is a licensed product and is not to be reproduced or redistributed
Do you have a subscription to Datamonitor Healthcare, Biomedtracker or Meddevicetracker? You may already have access to these reports, contact your account manager or email pharma@informabi.com for further help or assistance.
Sign up to the Pharma Intelligence Report Store Newsletter to get the latest blogs, news, reports and discounts!